Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Heptinstall

Platelets

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Platelets|April 13, 2005
Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromesMiles W H Behan, Susan C Fox, Stan Heptinstall, et al.
Platelets|January 10, 2004
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonistLian Zhao, Philip M W Bath, Jane May, et al.
Platelets|May 20, 2011
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMPDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|May 4, 2010
The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|January 20, 2006
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokeLian Zhao, Laura Gray, Jo Leonardi-Bee, et al.
Platelets|January 18, 2014
A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrelMark R Thomas, Yanushi D Wijeyeratne, Jane A May, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Platelets|April 13, 2005
Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromesMiles W H Behan, Susan C Fox, Stan Heptinstall, et al.
Platelets|January 10, 2004
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonistLian Zhao, Philip M W Bath, Jane May, et al.
Platelets|May 20, 2011
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMPDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|May 4, 2010
The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|January 20, 2006
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic strokeLian Zhao, Laura Gray, Jo Leonardi-Bee, et al.
Platelets|January 18, 2014
A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrelMark R Thomas, Yanushi D Wijeyeratne, Jane A May, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|July 29, 2009
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3Robert F Storey, S Melissa Thornton, Rachael Lawrance, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Pageof 2